Understanding Lamin A/C interactome and cell plasticity to identify novel therapeutic vulnerabilities in bone sarcomas

Title

Code

LAPIS

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366760

katia.scotlandi@ior.it

Scotlandi Katia, MSc

Head

Laboratory of Experimental Oncology

Operational unit that carry out the study

departmental simple unit

Laboratorio di Oncologia sperimentale

Head

Scotlandi Katia, MSc

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. LAPIS

Thursday 21 November 2024, 15:57

PG0016576_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Understanding Lamin A/C interactome and cell plasticity to identify novel therapeutic vulnerabilities in bone sarcomas

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in